Daily non-political popular news in brief.

Insulin -- in need of some restraint?

Knocking out the gene for a peptide associated with insulin secretion protects mice against the harmful effects of a high-fat diet, report researchers at the Salk Institute for Biological Studies. Their findings, detailed in the Proceedings of the National Academy of Sciences, suggest that urocortin 3, a new peptide recently discovered in the insulin secreting cells of the pancreas, plays a role in the increased production of insulin in response to high caloric intake in animals.

Read more »

Keywords: insulin, restraint

« Previous | Next »

Similar news on "Insulin -- in need of some restraint?":

1. Mercury Compound Found In Fish Damages Pancreatic Cells
   09-29-2006 · ScienceDaily
   Researchers in Taiwan say they have established for the first time that the mercury compound present as a contaminant in some seafood can damage insulin-producing cells in the pancreas.
   Similar news · Read more »
   
2. New fat, same old problem with an added twist?
   01-16-2007 · EurekAlert!
   Last month, New York City outlawed the use of partially hydrogenated oils, known as trans fats, in restaurants, a ban now under consideration in other cities, including Boston and Chicago. But novel research conducted in Malaysia and at Brandeis University shows that a new method of modifying fat in commercial products to replace unhealthy trans fats raises blood glucose and depresses insulin in humans, common precursors to diabetes. Furthermore, like trans fat, it still adversely depressed the beneficial HDL-cholesterol.
   Similar news · Read more »
   
3. Joslin study indicates insulin receptors play a critical role in promoting islet growth
   04-02-2007 · EurekAlert!
   A new Joslin-led study has identified the insulin receptor as an important protein that promotes islet cell growth in mice whose bodies are unable to use insulin properly, or are insulin resistant, a precursor to type 2 diabetes.
   Similar news · Read more »
   
4. JCI table of contents: May 24, 2007
   05-24-2007 · EurekAlert!
   This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online, May 24, 2007, in the JCI, including: "Stuck on you: CEACAM6 helps E. coli stick to intestinal lining in Crohn's disease"; "PPARgamma is required for the full effect of antidiabetic drugs"; "Mind over liver: Resistin's action in brain linked to liver insulin resistance"; "Gene Gas1 is involved in severe craniofacial malformations"; and others.
   Similar news · Read more »
   
5. Metabolic syndrome -- don't blame the belly fat
   07-16-2007 · EurekAlert!
   Abdominal fat, the spare tire that many of us carry, has long been implicated as a primary suspect in causing the metabolic syndrome, a cluster of conditions that includes the most dangerous heart attack risk factors: prediabetes, diabetes, high blood pressure, and changes in cholesterol. But researchers have found that insulin resistance in skeletal muscle leads to alterations in energy storage that set the stage for the metabolic syndrome.
   Similar news · Read more »
   
6. Immunosuppressive drugs are a double-edged sword to type 1 diabetics
   09-04-2007 · EurekAlert!
   Type 1 diabetes occurs when immune cells destroy pancreatic insulin producing beta-cells. It was hoped that islet transplantation would provide a cure for the disease, however, transplant success is short-lived and accompanied by significant side effects. New data indicate that the immunosuppressive drugs used to prevent islet transplant rejection suppress beta-cell regeneration in diabetic mice, raising the possibility that identifying immunosuppressive drugs that do not inhibit beta-cell regeneration might lead to successful regenerative islet transplantation.
   Similar news · Read more »
   
7. Benefit of exenatide has not yet been proven
   10-17-2007 · EurekAlert!
   Since May 2007, a new drug has been available for the treatment of patients with diabetes mellitus type 2 in Germany: exenatide (trade name: Byetta), which is marketed by the manufacturer Eli Lilly. According to current evidence, the blood-glucose lowering effect of exenatide has been demonstrated, but is not superior to the corresponding effect of insulin. Moreover, there is no evidence to show that the improved glycaemic control contributes to a reduction in the rate of late complications of diabetes.
   Similar news · Read more »
   
8. Human hormone blocker found to help prevent obesity and diabetes: study
   01-03-2008 · EurekAlert!
   A new study finds that a chemical found in the body is capable of promoting weight loss, improving insulin resistance and reversing diabetes in an animal model. The hormone is gastric inhibitory polypeptide receptor blockade.
   Similar news · Read more »
   
9. Duke researchers find physician resistance hinders diabetics use of cutting edge technology
   10-13-2006 · EurekAlert!
   Diabetic patients who use newer technologies such as insulin pumps and blood glucose monitoring devices are better able to manage their disease and adhere to treatment regimens, with less daily pain, than with conventional treatments, according to Duke University researchers. Yet researchers have found that the newer methods to manage diabetes are not being widely used because physicians may be reluctant to prescribe them, and even patients who are using them may not be deriving their full benefits.
   Similar news · Read more »
   
10. Cells passed from mother to child during pregnancy live on and make insulin
    01-22-2007 · EurekAlert!
    A Bristol team has looked for maternal cells in children with type 1 diabetes, an immune-mediated disorder, and found that around 20 percent of these children have unusually high levels of maternal DNA in their circulation.
    Similar news · Read more »